ZYBERNO
Stock Report
Updated Sep 1, 2026

PROFUSA, INC. (PFSA)

Healthcare • NASDAQ

$2.88

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
7.0/100
POOR BUSINESS
PROFUSA, INC. (PFSA) scores 7/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (0.0%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.00x)
Operating Margin (Operational Efficiency):CRITICAL (0.0%)
Return on Capital (Capital Efficiency):CRITICAL (0.0%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

PROFUSA, INC. (PFSA) stock report — Zyberno Score 7/100 (POOR BUSINESS). Full financial analysis on Zyberno.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:2.88
Market Cap:$1.61M

Valuation Multiples (2)

P/S Ratio:16.13x
Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:-$10.49M
B. Profitability Assessment

Return Metrics (2)

ROA:-1,559.8%
Reinvestment Rate:0.0%

Margin Analysis (1)

Ebitda Margin:-32,706.3%

Yield Metrics (2)

Earnings Yield:-$28.80K
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

EPS Surprise vs Expected:-1,227.1%
Latest Earnings Filed:2026-08-19

Earnings Growth (Linear) (1)

Net Income Growth Rate (Linear):-50.0%
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:0.03x
Quick Ratio:0.03x
Cash Ratio:0.43x

Leverage Analysis (1)

Debt To Ebitda:-999.00x

Coverage Ratios (2)

Interest Coverage Ratio:-5.57x
Times Interest Earned:-5.57

Capital Structure (4)

Working Capital:-27,326,000.00
Cash And Cash Equivalents:12,200,000.00
Long Term Debt:$100.00K
Net Debt:-$12.10M
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

$100.00K
Cost Of Revenue Ttm:$0.00

Profitability Breakdown (2)

$0.00-$32.71M

Bottom Line Performance (3)

Net income TTM: -$38.72M
Linear Growth: -50.0%
📊 Click to view full PFSA Net Income analysis & methodology →
Income Before Tax:-$16.75M
Ebitda Ttm:-32,706,335.00

Operating Expenses (5)

Operating Expenses:34,257,000.00
R And D Expense:823,000.00
Sga Expense:1,722,000.00
Income Tax Expense:$57.77K
Interest Expense:808,000.00

Expense Ratios (3)

R And D To Revenue Percentage:1,097.3%
Sga To Revenue Percentage:2,296.0%
Ebitda Margin:-32,706.3%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$1.04M
Current Assets:$841.00K
Ppe Net:84,000.00
Goodwill:0.00
Intangible Assets:$0.00

Liability Structure (4)

Total Liabilities:28,169,000.00
Current Liabilities:28,167,000.00
Long Term Debt:$100.00K
Short Term Debt:$0.00

Equity & Capital (3)

Equity:-$27.13M
Retained Earnings:-$172.99M
Common Stock:600,000,000.00

Working Capital Items (3)

Accounts Receivable:0.00
Inventory:0.00
Accounts Payable:7,855,000.00

Special Items (2)

Contract Liabilities:0.00
Stock Based Compensation:188,000.00
C. Cash Flow Analysis

Operating Activities (2)

-$18.46M-$16.26M

Investment Activities (1)

Investing Cash Flow:$1.15M

Financing Activities (3)

Financing Cash Flow:$28.00K
Dividends Paid Ttm:0.00
Stock Repurchase:6,510,830.00

Capital Transactions (3)

Common Stock Issuance:0.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$1.92M
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-259.14
Eps diluted TTM: -$259.14
Linear Growth: -23.6%
📊 Click to view full PFSA EPS analysis & methodology →
Earnings Per Share Ttm:-$69.15

Revenue & Cash Per Share (2)

Sales Per Share Ttm:0.18
Operating Cash Flow Per Share:-$3.69

Book Value & Capital (2)

Book Value Per Share:-$48.45
Cash Per Share:21.79

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:0.04x
Working Capital Turnover Ttm:-999.00x

Receivables Management (2)

Receivables Turnover Ttm:-999.00x
Days Sales Outstanding Ttm:-999.00

Inventory Management (2)

Inventory Turnover Ttm:-999.00x
Days Inventory Outstanding Ttm:-999.00

Payables & Cash Cycle (2)

Days Payable Outstanding:28,670.75
Cash Conversion Cycle:-30,668.75
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:20.00
Quality Score:20.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Damodaran Growth Analysis (1)

Reinvestment Rate:0.0%
B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (1)

Net Income Growth Rate (Linear):-50.0%
C. Company Profile & Context

Corporate Information (6)

Symbol:PFSA
Company Name:PROFUSA, INC.
Sector:Healthcare
Industry:Medical Devices
Exchange:NASDAQ
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:penny
Volume Category:N/A

Share Structure (3)

Shares Outstanding:559.92K
Shares Outstanding Basic:57.68K
Shares Outstanding Diluted:57.68K

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-09-01 22:03:35 UTC
Data Timestamp:2026-08-22T16:02:15.343929
Scroll to Top